Avalo Therapeutics (AVTX) Other Operating Expenses (2017 - 2024)
Avalo Therapeutics (AVTX) reported Other Operating Expenses of $87000.0 for Q4 2024, down 97.64% on a YoY basis from $3.7 million in Q1 2024, and up 112.18% quarter-over-quarter from -$714000.0 in Q3 2024.
Avalo Therapeutics (AVTX) Other Operating Expenses (2017 - 2024) Analysis & Trends
Avalo Therapeutics has reported Other Operating Expenses for 7 years, with the latest figure at $87000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Operating Expenses fell 97.64% year-over-year to $87000.0; the trailing twelve-month figure through Sep 2025 stood at $87000.0 (down 99.72% YoY), and the FY2024 full-year result was $27.3 million, up 425.43% from the prior year.
- Other Operating Expenses for Q4 2024 stood at $87000.0, up from -$714000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $27.5 million in Q1 2024, with the low at -$714000.0 in Q3 2024.
- Historically, Other Operating Expenses has averaged $2.5 million across 4 years, with a median of $655500.0 in 2021.
- The largest YoY upside for Other Operating Expenses was 4883.3% in 2024 against a maximum downside of 389.07% in 2024.
- Avalo Therapeutics' Other Operating Expenses stood at $691000.0 in 2021, then declined by 10.27% to $620000.0 in 2022, then jumped by 494.52% to $3.7 million in 2023, then plunged by 97.64% to $87000.0 in 2024.
- The last three Other Operating Expenses figures came in at $87000.0 (Q4 2024), -$714000.0 (Q3 2024), and $446000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | -714,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 27.46 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 247,000.00 |
| Jun 30, 2023 | 708,000.00 |
| Mar 31, 2023 | 551,000.00 |
| Dec 31, 2022 | 620,000.00 |
| Sep 30, 2022 | 528,000.00 |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 758,000.00 |
| Dec 31, 2021 | 691,000.00 |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 511,000.00 |
| Mar 31, 2021 | 936,000.00 |
| Dec 31, 2019 | 1.00 |
| Jun 30, 2019 | 1.28 Mn |
| Mar 31, 2019 | -20,940.00 |
| Dec 31, 2018 | 471,773.00 |